Zealand Pharma A/s Aktie
56,30 €
Deine Einschätzung
Zealand Pharma A/s Aktie
Was spricht für und gegen Zealand Pharma A/s in den nächsten Jahren?
Pro
Kontra
Rendite von Zealand Pharma A/s im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -4,04 % | -8,90 % | -16,77 % | -42,32 % | -12,00 % | 106,83 % | - |
| Saniona AB | 1,67 % | 0,73 % | -0,61 % | 220,26 % | 1,36 % | 616,02 % | -7,87 % |
| Actinium Pharmaceuticals Inc. | 2,86 % | 2,85 % | -2,94 % | -7,32 % | -1,41 % | -86,41 % | -82,37 % |
| NanoViricides Inc. | 0,99 % | 0,00 % | -9,73 % | -22,73 % | 9,68 % | -17,54 % | -61,65 % |
Kommentare
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big



